Human herpesvirus 6 (HHV6), a member of the ß-herpesvirus subfamily, exists as 2 closely related variants, HHV6 A and HHV6 B.
Epidemiology
Incidence – most children >2 years are seropositive
Transmission
Oral droplets
Transfusion
Organ transplantation
Organism
DNA virus
Isolated in 1986 from patients with AIDS and lymphoproliferative disease, the virus was originally named human B-lymphotropic virus (HBLV)
Following the primary infection, the virus establishes a latent infection in lymphocytes and monocytes and may persist in various tissues with a low-level of replication
Clinical Presentation
Primary infection with HHV6 produces a fever that may exceed 40°C, persisting for 3-5 days
Primary infections in children often result in a fever followed by development of exanthem subitum, known as roseola infantum or sixth disease
Rash develops on trunk and spreads to extremities
Primary infections in adults, though rare, may involve:
Infectious mononucleosis-like disease
Fulminant hepatitis
Atypical lymphocytosis
Associated complications may include:
Meningitis
Meningoencephalitis
Fulminant or chronic hepatitis
Evidence suggests HHV6 may act as an opportunistic agent in:
Immunodeficient patients undergoing bone marrow or organ transplants
HIV-infected individuals by means of primary infection reactivation of a latent infection or a persistent infection
In immunocompromised or immunosuppressed patients
Symptoms -- Fever, skin rash, organ disease or rejection, encephalitis, encephalopathy, pneumonitis, hepatitis, bone marrow suppression and death
Evidence based clinical practice guideline for fever of uncertain source in children 2 to 36 months of age. Cincinnati Children's Hospital Medical Center - Hospital/Medical Center. 2000 Feb (revised 2003 Oct 27). 12 pages. NGC:003783
(Link to NGC)
Evidence based clinical practice guideline for fever of uncertain source in infants 60 days of age or less. Cincinnati Children's Hospital Medical Center - Hospital/Medical Center. 1998 Sep 10 (revised 2003 Jun). 12 pages. NGC:003166
(Link to NGC)
General References
Clark DA, Griffiths PD.Human herpesvirus 6: relevance of infection in the immunocompromised host.Br J Haematol. 2003;120(3):384-395. (Link to PubMed)
Fotheringham J, Jacobson S.Human herpesvirus 6 and multiple sclerosis: potential mechanisms for virus-induced disease.Herpes. 2005;12(1):4-9. (Link to PubMed)
Krueger GR, Ablashi DV.Human herpesvirus-6: a short review of its biological behavior.Intervirology. 2003;46(5):257-269. (Link to PubMed)
Ward KN.Human herpesviruses-6 and -7 infections.Curr Opin Infect Dis. 2005;18(3):247-252. (Link to PubMed)
Ward KN.The natural history and laboratory diagnosis of human herpesviruses-6 and -7 infections in the immunocompetent.J Clin Virol. 2005;32(3):183-193. (Link to PubMed)
Zerr DM.Human herpesvirus 6: a clinical update.Herpes. 2006;13(1):20-24. (Link to PubMed)
References from the ARUP Institute for Clinical and Experimental Pathology®
Herrmann MG, Durtschi JD, Bromley LK, Wittwer CT, Voelkerding KV.Amplicon DNA melting analysis for mutation scanning and genotyping: cross-platform comparison of instruments and dyes.Clin Chem. 2006;52(3):494-503. (Link to PubMed)
Hymas W, Stevenson J, Taggart EW, Hillyard D.Use of lyophilized standards for the calibration of a newly developed real time PCR assay for human herpes type six (HHV6) variants A and B.J Virol Methods. 2005;128(1-2):143-150. (Link to PubMed)
Rentz AC, Stevenson J, Hymas W, Hillyard D, Stoddard GJ, Taggart EW, Byington CL.Human herpesvirus 6 in the newborn intensive care unit.Eur J Clin Microbiol Infect Dis. 2007;26(4):297-299. (Link to PubMed)
Reviewed by
Hillyard, David R., M.D. Medical Director, Molecular Infectious Diseases at ARUP Laboratories; Associate Professor, Pathology, University of Utah
Comprehensive Review: November 2007
Last Update: November 2007